Clinical safety of gadopentetate dimeglumine.
KL Nelson, LM Gifford, C Lauber-Huber, CA Gross… - Radiology, 1995 - pubs.rsna.org
PURPOSE: To quantify the rate of adverse reactions to gadopentetate dimeglumine.
MATERIALS AND METHODS: Magnetic resonance (MR) imaging was performed in 15,496 …
MATERIALS AND METHODS: Magnetic resonance (MR) imaging was performed in 15,496 …
Endothelial cell damage in sarcoidosis and neurosarcoidosis: autoantibodies to endothelial cells
N Tsukada, N Yanagisawa, I Mochizuki - European neurology, 1995 - karger.com
Damage to the vascular system, of which endothelial cells are the main constituent, may
occur in sarcoidosis. Evidence of blood-brain barrier (BBB) disruption is shown in …
occur in sarcoidosis. Evidence of blood-brain barrier (BBB) disruption is shown in …
In vivo MRI visualization of acute myocardial ischemia and reperfusion in ferrets by the persistent action of the contrast agent Gd (BME-DTTA)
T Simor, WJ Chu, L Johnson, A Safranko, M Doyle… - Circulation, 1995 - Am Heart Assoc
Background Contrast agent–enhanced magnetic resonance imaging (MRI) has the potential
to visualize myocardial ischemia. To date, however, no agent has been found that has a …
to visualize myocardial ischemia. To date, however, no agent has been found that has a …
Gadolinium and dysprosium chelates of DTPA‐amide‐dextran: synthesis, 1H NMR relaxivity, and induced 23Na NMR shift
WJ Chu, GA Elgavish - NMR in Biomedicine, 1995 - Wiley Online Library
In this study the conjugated macromolecular ligand, diethylenetriaminepentaacetic acid
(DTPA)‐amide‐dextran, was synthesized by attaching DTPA to the dextran macromolecule …
(DTPA)‐amide‐dextran, was synthesized by attaching DTPA to the dextran macromolecule …
[图书][B] The NMR proton relaxation effectiveness of paramagnetic metal ions and their potential as MRI contrast agents
GD Waiter - 1995 - search.proquest.com
Paramagnetic lanthanide ions have been investigated as possible MIR phantom materials
and contrast agents. The aim of this study is to determine if it is possible to apply the well …
and contrast agents. The aim of this study is to determine if it is possible to apply the well …
Phase III multicenter evaluation of high-dose gadoteridol in neurologic pathology: comparison of 0.1 mmol/kg gadopentetate dimeglumine and 0.3 mmol/kg …
H Youssef, M Kuhn, G Hammer, L Meis, T Burk… - Proceedings of the XV …, 1995 - Springer
In this phase III multicenter study, 164 patients with suspected intracranial or spinal
pathology underwent magnetic resonance imaging (MRI) to evaluate the safety of …
pathology underwent magnetic resonance imaging (MRI) to evaluate the safety of …